Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

O preço da ação Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) pre-market hoje é de $ 0,92, refletindo uma movimentação de -4,02% pre-market desde que o mercado fechou. A capitalização de mercado da empresa é de $ 3,00 mi, com um volume comercial diário de $ 13,00 ações. O preço de fechamento anterior foi $ 0,96.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Shuttle Pharmaceuticals ações na Kraken a partir de US$ 10.